Palvella Therapeutics, Inc. Preferred Stock, Shares Issued
Palvella Therapeutics, Inc. (PVLA) had Preferred Stock, Shares Issued of 0 shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2026-03-31
- 2025-12-31: Preferred Stock, Shares Issued 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Issued 15.62K shares.
- 2025-06-30: Preferred Stock, Shares Issued 15.62K shares.
- 2025-03-31: Preferred Stock, Shares Issued 15.62K shares.
| Period end | Preferred Stock, Shares Issued | Preferred Stock, Shares Issued as first filed |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-31 | |
| 2025-09-30 | 15.62K shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 15.62K shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 15.62K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 15.62K shares 10-K · filed 2026-03-31 | |
| 2024-12-13 | 15.62K shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 15.62K shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 15.62K shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 15.62K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-31 | 15.62K shares 10-K · filed 2024-03-29 |
| 2023-09-30 | 15.62K shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 15.62K shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 15.62K shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 15.62K shares 10-K · filed 2024-03-29 | |
| 2022-09-30 | 15.62K shares 10-Q · filed 2022-11-04 | |
| 2022-06-30 | 15.62K shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 15.62K shares 10-Q · filed 2022-05-11 | |
| 2021-12-31 | 15.62K shares 10-K · filed 2023-03-31 | |
| 2021-09-30 | 15.62K shares 10-Q · filed 2021-11-02 | |
| 2021-06-30 | 15.62K shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 14.43K shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 14.43K shares 10-K · filed 2022-03-02 | |
| 2020-09-30 | 14.43K shares 10-Q · filed 2020-11-04 | |
| 2020-06-30 | 14.43K shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 11.43K shares 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 11.43K shares 10-K · filed 2021-03-31 | |
| 2018-12-31 | 2.91K shares 10-K · filed 2019-03-18 | |
| 2018-09-30 | 2.91K shares 10-Q · filed 2018-11-07 | |
| 2018-06-30 | 2.91K shares 10-Q · filed 2018-08-09 | |
| 2018-03-31 | 2.91K shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 4.96K shares 10-K · filed 2019-03-18 | |
| 2017-09-30 | 4.96K shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 4.96K shares 10-Q · filed 2017-08-11 | |
| 2017-03-31 | 4.96K shares 10-Q · filed 2017-05-15 | |
| 2016-12-31 | 4.96K shares 10-K · filed 2018-03-15 | |
| 2016-09-30 | 4.96K shares 10-Q · filed 2016-11-10 | |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-03-30 | |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-23 | |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |